Trial watch: an update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatment by Mafalda Penetra, Luís G. Arnaut, Lígia C. Gomes-da-Silva

“…In the last decade, several clinical trials on PDT for cancer treatment have been initiated, indicating that significant efforts are being made to improve current PDT protocols. …”
Get full text

Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis by Hui‐Zhong Jiang, Ya‐Li Jiang, Bing Yang, Feng‐Xi Long, Zhu Yang, Dong‐Xin Tang

Get full text

Measurement of the Association of Pain with Clinical Characteristics in Oral Cancer Patients at Diagnosis and Prior to Cancer Treatment by Sawicki CM, Janal MN, Gonzalez SH, Wu AK, Schmidt BL, Albertson DG

Get full text

Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment by Kabagwira J, Fuller RN, Vallejos PA, Sugiono CS, Andrianarijaona VM, Chism JB, O'Leary MP, Caba Molina D, Langridge W, Senthil M, Wall NR

Get full text

Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022 by Lady Paola Aristizabal Arboleda, Aline Borburema Neves, Hugo Fontan Kohler, José Guilherme Vartanian, Letícia Miliano Candelária, Matheus Ferraz Borges, Gisele Aparecida Fernandes, Genival Barbosa deCarvalho, Luiz Paulo Kowalski, Paul Brennan, Alan Roger Santos‐Silva, Maria Paula Curado

“…Aim The present review was conducted to identify changes in the NCCN guidelines for glottic cancer treatment made between 2011 and 2022 and to describe the published evidence concerning glottic cancer treatment and oncological outcomes in the same time period. …”
Get full text

Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment by Duopeng An, Xiaochen Yu, Lijing Jiang, Rui Wang, Peng He, Nanye Chen, Xiaohan Guo, Xiang Li, Meiqing Feng

“…These features indicate that the designed liposomes represent a promising strategy for the reversal of MDR in cancer treatment.…”
Get full text

MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment by André T. S. Vicente, Jorge A. R. Salvador

“…The incorporation of ligands that recruit mouse double minute 2 (MDM2) into PROTACs, forming the so-called MDM2-based PROTACs, has shown promise in cancer treatment due to its dual mechanism of action: a PROTAC that recruits MDM2 prevents its binding to p53, resulting not only in the degradation of POI but also in the increase of intracellular levels of the p53 suppressor, with the activation of a whole set of biological processes, such as cell cycle arrest or apoptosis. …”
Get full text

Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment by Zhao Y, Tan H, Zhang J, Pan B, Wang N, Chen T, Shi Y, Wang Z

Get full text

3506 PRMT5 is a novel therapeutic target to enhance radiation therapy for cancer treatment by Jake L Owens, Elena Beketova, Samantha Tinsley, Andrew Asberry, Xuehong Deng, Chang-Deng Hu

“…Lastly, because targeting DSB repair is a clinically validated therapeutic approach for cancer treatment, our findings also suggest that PRMT5 targeting may be explored as a monotherapy or in combination therapy with radiation therapy or chemotherapy for cancer treatment.…”
Get full text

Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis by Hui Zhou, Zhongtao Liu, Zijian Zhang, Nil Kanatha Pandey, Eric Amador, William Nguyen, Lalit Chudal, Li Xiong, Wei Chen, Yu Wen

“…Herein, we report microwave induced copper-cysteamine (Cu-Cy) nanoparticles-based PDT as a promising cancer treatment to overcome cancer resistance in combination with ferroptosis. …”
Get full text

Standardizing Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Treatment: Navigating Complexities and Charting the Path Forward by Juan José Segura-Sampedro, Pedro Cascales-Campos

Get full text

Poly (ADP-ribose) polymerase inhibitor: A new horizon in advanced prostate cancer treatment by Minyong Kang, Seong Soo Jeon

Get full text

Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment by Sarah Kofoed, Sibilah Breen, Karla Gough, Sanchia Aranda

“…In Australia, the incidence of cancer diagnoses is rising along with an aging population. Cancer treatments, such as chemotherapy, are increasingly being provided in the ambulatory care setting. …”
Get full text

Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects by Elham Aram, Masome Moeni, Roya Abedizadeh, Davood Sabour, Hamid Sadeghi-Abandansari, Jabbar Gardy, Ali Hassanpour

Get full text

The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review by Baonan Dong, Hui Zhan, Ting Luan, Jiansong Wang

Get full text

Improving Breast Cancer Treatment Specificity Using Aptamers Obtained by 3D Cell-SELEX by Frank H. T. Nelissen, Wenny J. M. Peeters, Timo P. Roelofs, Anika Nagelkerke, Paul N. Span, Hans A. Heus

Get full text

Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations by Ali Sartaj, Zufika Qamar, Farheen Fatima Qizilbash, Annu, Shadab Md, Nabil A. Alhakamy, Sanjula Baboota, Javed Ali

“…This manuscript aims to provide the latest update on polymeric nanoparticle drug delivery system for breast cancer treatment after 2015 and how research-oriented it is based on the available research data. …”
Get full text

Changes in Nutrition Impact Symptoms, Nutritional and Functional Status during Head and Neck Cancer Treatment by May Kay Neoh, Zalina Abu Zaid, Zulfitri Azuan Mat Daud, Nor Baizura Md. Yusop, Zuriati Ibrahim, Zuwariah Abdul Rahman, Norshariza Jamhuri

Get full text

Two-dimensional nanomaterials induced nano-bio interfacial effects and biomedical applications in cancer treatment by Yan Wang, Xiao Zhang, Hua Yue

Subjects: Get full text

A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies by OPhir Nave, Moria Sigron

Subjects: Get full text